IL1F10 and fatty liver disease: Recent studies have shown that IL-38 alleviates hepatic steatosis by suppressing lipogenic protein expression and endoplasmic reticulum stress markers, thereby reducing lipid accumulation [28], which is consistent with the experimental results of our study.